Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis

Research

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6019 (Published 08 December 2015) Cite this as: BMJ 2015;351:h6019

Data supplement

Is there a genuine placebo effect in acute depression treatments? A reassessment of regression to the mean and spontaneous remission
- Abstract
- Fulltext
- PDF
Depression in primary care: part 2--management
- Abstract
- Fulltext
- PDF
Morita Therapy for depression (Morita Trial): a pilot randomised controlled trial
- Abstract
- Fulltext
- PDF
Frequency of reporting on patient and public involvement (PPI) in research studies published in a general medical journal: a descriptive study
- Abstract
- Fulltext
- PDF
Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
- Abstract
- Fulltext
- PDF
Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation
- Abstract
- Fulltext
- PDF
Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials
- Abstract
- Fulltext
- PDF
Non-pharmacological treatment of depression: a systematic review and evidence map
- Abstract
- Fulltext
- PDF
Treating seasonal affective disorder with cognitive behavioural therapy is comparable to light therapy
- Abstract
- Fulltext
- PDF
The problem of accessing psychotherapies for depression in the UK
- Abstract
- Fulltext
- PDF
Cognitive behavioural therapy or antidepressants for acute depression?
- Abstract
- Fulltext
- PDF